Condensed Consolidated Statements of Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Treasury Stock, Common	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Stockholders equity, Beginning balance at Dec. 31, 2022	$ 2,000	$ 199,492,000	$ (35,000)	$ (161,000)	$ (150,266,000)	$ 49,032,000
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2022	23,312,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon stock option exercises	$ 0	1,466,000	0	0	0	$ 1,466,000
Issuance of common stock upon stock option exercises (in shares)	1,239,899					1,239,899
Stock-based compensation	$ 0	2,208,000	0	0	0	$ 2,208,000
Stock based compensation (in shares)	0
Vesting of restricted common stock	$ 0	1,000	0	0	0	1,000
Vesting of restricted common stock (in shares)	3,946
Vesting of restricted stock units, net of withholding	$ 0	0	(19,000)	0	0	(19,000)
Vesting of restricted stock units, net of withholding (in shares)	15,578
Unrealized (loss) gain on marketable securities	$ 0	0	0	159,000	0	159,000
Net Income (Loss)	0	0	0	0	(27,169,000)	(27,169,000)
Stockholders equity, Ending balance at Jun. 30, 2023	$ 4,000	249,668,000	(54,000)	(2,000)	(177,435,000)	72,181,000
Stockholders equity, Ending balance (in shares) at Jun. 30, 2023	42,381,952
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs	$ 2,000	46,501,000	0	0	0	46,503,000
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs (in shares)	17,810,000
Stockholders equity, Beginning balance at Mar. 31, 2023	$ 2,000	201,185,000	(47,000)	(51,000)	(167,325,000)	33,764,000
Stockholders equity, Beginning balance (in shares) at Mar. 31, 2023	23,786,337
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon at-the-market offering, net of issuance costs	$ 2,000	46,501,000				46,503,000
Issuance of common stock upon at-the-market offering, net of issuance costs (in shares)	17,810,000
Issuance of common stock upon stock option exercises		1,238,000				1,238,000
Issuance of common stock upon stock option exercises (in shares)	777,826
Stock-based compensation		744,000				744,000
Vesting of restricted stock units, net of withholding			(7,000)			(7,000)
Vesting of restricted stock units, net of withholding (in shares)	7,789
Unrealized (loss) gain on marketable securities				49,000		49,000
Net Income (Loss)					(10,110,000)	(10,110,000)
Stockholders equity, Ending balance at Jun. 30, 2023	$ 4,000	249,668,000	(54,000)	(2,000)	(177,435,000)	72,181,000
Stockholders equity, Ending balance (in shares) at Jun. 30, 2023	42,381,952
Stockholders equity, Beginning balance at Dec. 31, 2023	$ 4,000	250,825,000	(59,000)	9,000	(195,970,000)	54,809,000
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2023	42,422,531
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon at-the-market offering, net of issuance costs	$ 1,000	44,206,000	0	0		44,207,000
Issuance of common stock upon at-the-market offering, net of issuance costs (in shares)	11,625,295
Issuance of common stock upon stock option exercises	$ 0	487,000	0	0		$ 487,000
Issuance of common stock upon stock option exercises (in shares)	366,947					366,947
Issuance of common stock upon exercise of common warrants	$ 0	450,000	0	0		$ 450,000
Issuance of common stock upon exercise of common warrants (in shares)	200,000
Warrant issuance	$ 0	261,000	0	0		261,000
Stock-based compensation	$ 0	1,949,000	0	0		1,949,000
Stock based compensation (in shares)	0
Vesting of restricted stock units, net of withholding	$ 0	0	(42,000)	0		(42,000)
Vesting of restricted stock units, net of withholding (in shares)	39,722
Unrealized (loss) gain on marketable securities	$ 0	0	0	(35,000)		(35,000)
Net Income (Loss)	0	0	0	0	(21,168,000)	(21,168,000)
Stockholders equity, Ending balance at Jun. 30, 2024	$ 5,000	298,178,000	(101,000)	(26,000)	(217,138,000)	80,918,000
Stockholders equity, Ending balance (in shares) at Jun. 30, 2024	54,654,495
Stockholders equity, Beginning balance at Mar. 31, 2024	$ 5,000	282,575,000	(85,000)		(206,677,000)	75,818,000
Stockholders equity, Beginning balance (in shares) at Mar. 31, 2024	51,679,383
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon at-the-market offering, net of issuance costs		14,551,000				14,551,000
Issuance of common stock upon at-the-market offering, net of issuance costs (in shares)	2,958,879
Issuance of common stock upon stock option exercises		5,000				5,000
Issuance of common stock upon stock option exercises (in shares)	4,000
Stock-based compensation		1,047,000				1,047,000
Vesting of restricted stock units, net of withholding			(16,000)			(16,000)
Vesting of restricted stock units, net of withholding (in shares)	12,233
Unrealized (loss) gain on marketable securities				(26,000)		(26,000)
Net Income (Loss)					(10,461,000)	(10,461,000)
Stockholders equity, Ending balance at Jun. 30, 2024	$ 5,000	$ 298,178,000	$ (101,000)	$ (26,000)	$ (217,138,000)	$ 80,918,000
Stockholders equity, Ending balance (in shares) at Jun. 30, 2024	54,654,495